Stay up to date with the latest news about DCRI and Duke presentations at this year’s Scientific Sessions of the American College of Cardiology in Orlando, FL.

Late-Breaking Clinical Trials

Stay tuned to learn more about the results of these late-breaking clinical trials.

  • ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial
  • DEFINE-FLAIR: Comparative Cost Effectiveness of the Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Coronary Revascularization Decision-making
  • ARTEMIS: Impact of Patient Copayment Reduction on P2Y12Inhibitor Persistence and Clinical Outcomes after Myocardial Infarction: The Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS) Randomized Trial
  • TREAT Trial: A Phase III, Randomized, International, Multicenter, Open label, with Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome with ST Elevation Treated with Thrombolysis
  • SECURE-PCI Trial: Loading Doses of Atorvastatin versus Placebo in Patients with Acute Coronary Syndromes and Planned Revascularization
  • INDIE-HFpEF: Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure with Preserved Ejection Fraction: The INDIE Trial
  • GWTG-HF Registry: Hospital Performance based on 30-Day Risk Standardized Mortality and Long-Term Survival after Heart Failure Hospitalization: An Analysis of Get With The Guidelines-Heart Failure

Get in Touch With Us

Attending ACC this year? Want to speak with one of our faculty members? To schedule a meeting at ACC.18,
contact Martin Hunicutt.

ACC.18 News

ACC 2018